If we look at it from the perspective of an up-thrust test, as we’ll do below, such tests if they don’t fail are the precursor to dynamic moves.
At the minimum, today’s action allows the stop to be moved on short position LABD-22-03 (not advice, not a recommendation).
It’s interesting, the biotech sector both IBB and SPBIO, with inverse funds BIS, and LABD, respectively are the only ones taking a major hit today.
Using a cue from Nicolas Darvas and his observations (as a dancer), the market will initially go opposite its main direction as if to get ready for the move; like a dancer crouching down before lifting the female partner.
That may or may not be the case now, as we’ll see below.
Biotech SPBIO, Weekly Chart
Next, we’re going to invert the chart (to mimic inverse LABD) and then label the up-thrust as a Wyckoff ‘Spring’.
Biotech SPBIO, Weekly Inverted
Next, we get closer to the action as shown.
Is the ??? area, a test or a failure of the set-up?
The short answer with about 90-minutes to go before the close, is unknown.
If SPBIO, closes down for the week, painting a red bar, probabilities are to the downside.
Closing higher for the week starts to bring a potential failure of the trade into question.
No matter what happens, the stop on the short position via LABD is going to be moved to the low of this session; currently LABD 49.90 (not advice, not a recommendation).
We may get into speculation later, on why biotech seems to be the only index in a major squeeze, preparing for downside.
Some who monitor this site, and those ‘awake’, may already have a good idea as to the potential why.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279